ClinicalTrials.gov
public full text
Public Domain
Bio-availability of a New Liquid Tumeric Extract
Curcumin is a commonly-used spice and food coloring. Evidence suggests that curcumin can suppress tumor initiation, promotion and metastasis in a variety of tumor cell lines. The current available curcumin has low bioavailability restricting the effect of curcumin in non-colon cancer. In this study we plan to test a new liquid tumeric/curcumin extract, Curcumol (patent pending, Israel Patent Application No. 181,121). We predict the bioavailability of the liquid tumeric/curcumin extract will be better compared to the currently used curcumin powder.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of Curcumin in Patients in Chronic Kidney Disease#969903
- Saffron as Anti Inflammatory In Patients With Inflammatory Bowel Disease#969383
- Evaluation of Curcumin's Effect on Inflammation in Hemodialysis Patients#1113335
- CuraLin Herbal Supplement for Type 2 Diabetes#1101129
- Effect of curcuminoids on 5-lipoxygenase product formation in activated neutrophils#1025322
Record · ID 873673
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive